Dae‐Seog Heo

469 total citations
22 papers, 371 citations indexed

About

Dae‐Seog Heo is a scholar working on Pharmacology, Oncology and Genetics. According to data from OpenAlex, Dae‐Seog Heo has authored 22 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in Dae‐Seog Heo's work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Dae‐Seog Heo is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Dae‐Seog Heo collaborates with scholars based in South Korea, United States and Ethiopia. Dae‐Seog Heo's co-authors include Myung‐Whun Sung, Seok‐Woo Park, Seokwoo Park, Bumjung Park, Jong‐Lyel Roh, Sang‐Goo Lee, Kwanghyun Kim, Dong‐Wook Lee, Hong‐Gyun Wu and Hiroyasu Inoue and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Dae‐Seog Heo

22 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dae‐Seog Heo South Korea 11 116 114 81 77 62 22 371
Arata Kimura Japan 9 58 0.5× 171 1.5× 99 1.2× 131 1.7× 8 0.1× 12 401
Chiharu Doi Japan 13 111 1.0× 32 0.3× 288 3.6× 103 1.3× 8 0.1× 20 571
Jessica Furriol Norway 11 67 0.6× 27 0.2× 217 2.7× 25 0.3× 8 0.1× 28 437
Hiroaki Tsurumaki Japan 13 127 1.1× 25 0.2× 193 2.4× 41 0.5× 11 0.2× 33 515
Masakiyo Yatomi Japan 10 54 0.5× 26 0.2× 145 1.8× 34 0.4× 11 0.2× 33 422
Juanjuan Che China 13 149 1.3× 11 0.1× 273 3.4× 63 0.8× 12 0.2× 20 512
Fangfang Gao China 16 159 1.4× 12 0.1× 264 3.3× 51 0.7× 11 0.2× 44 543
Linhai Zhu China 14 183 1.6× 16 0.1× 272 3.4× 95 1.2× 6 0.1× 55 605
Haruka Aoki‐Saito Japan 9 28 0.2× 23 0.2× 120 1.5× 29 0.4× 11 0.2× 17 314
Xiaoping Wu China 10 44 0.4× 38 0.3× 97 1.2× 45 0.6× 6 0.1× 23 319

Countries citing papers authored by Dae‐Seog Heo

Since Specialization
Citations

This map shows the geographic impact of Dae‐Seog Heo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae‐Seog Heo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae‐Seog Heo more than expected).

Fields of papers citing papers by Dae‐Seog Heo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae‐Seog Heo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae‐Seog Heo. The network helps show where Dae‐Seog Heo may publish in the future.

Co-authorship network of co-authors of Dae‐Seog Heo

This figure shows the co-authorship network connecting the top 25 collaborators of Dae‐Seog Heo. A scholar is included among the top collaborators of Dae‐Seog Heo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae‐Seog Heo. Dae‐Seog Heo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Min Kyu, Dongryul Oh, Kwan Ho Cho, et al.. (2015). Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy. Cancer Research and Treatment. 47(4). 871–878. 20 indexed citations
2.
Chin, Jacqueline, et al.. (2012). Integration of palliative and supportive cancer care in Asia. The Lancet Oncology. 13(5). 445–446. 4 indexed citations
3.
Park, Seok‐Woo, Hyosun Kim, Ji‐Eun Kim, et al.. (2011). The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines. Anti-Cancer Drugs. 22(5). 416–423. 7 indexed citations
5.
Heo, Dae‐Seog, et al.. (2010). Justifying the Information on Hospice Care that octors should provide to Terminally Ill Patients. Korean Journal of Medical Ethics. 13(2). 107–122. 1 indexed citations
6.
Freedman, Arnold S., John Kuruvilla, Sarit Assouline, et al.. (2010). Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592). Blood. 116(21). 284–284. 11 indexed citations
7.
8.
Chang, Ah Ram, Hong‐Gyun Wu, Charn Il Park, et al.. (2005). Retrospective Analysis of the Treatment Results for Patients with Squamous Cell Carcinoma of Tonsil. Cancer Research and Treatment. 37(2). 92–92. 5 indexed citations
9.
Lee, Dong Wook, et al.. (2004). Effects of p53 or p27 overexpression on cyclooxygenase‐2 gene expression in head and neck squamous cell carcinoma cell lines. Head & Neck. 26(8). 706–715. 8 indexed citations
10.
Roh, Jong‐Lyel, Myung‐Whun Sung, Seok‐Woo Park, et al.. (2004). Celecoxib Can Prevent Tumor Growth and Distant Metastasis in Postoperative Setting. Cancer Research. 64(9). 3230–3235. 34 indexed citations
11.
Kim, Dong‐Wan, Jong‐Mu Sun, Do‐Youn Oh, et al.. (2003). An Analysis of Treatment Results of Lymphoblastic Lymphoma in Adults According to the Chemotherapy Regimens. Blood Research. 38(1). 32–39. 1 indexed citations
12.
Kim, Dong‐Wan, Min‐Hee Ryu, Tae‐You Kim, et al.. (2003). A multivariate analysis of prognostic factors in colorectal cancer. The Korean Journal of Internal Medicine. 64(3). 268–274. 5 indexed citations
13.
Ryu, Min‐Hee, Bong-Seog Kim, Tae‐Won Kim, et al.. (2003). Subclassification of diffuse large B-cell lymphomas according to the REAL classification: Distinction of immunoblastic and non-immunoblastic subtypes. The Korean Journal of Internal Medicine. 65(1). 71–80. 1 indexed citations
14.
Park, Seokwoo, Sang‐Goo Lee, Sang‐Hyun Song, et al.. (2003). The effect of nitric oxide on cyclooxygenase‐2 (COX‐2) overexpression in head and neck cancer cell lines. International Journal of Cancer. 107(5). 729–738. 56 indexed citations
15.
Kim, Hoon-Kyo, Se‐Hoon Lee, Keunchil Park, et al.. (2003). 18 A multi-center, phase II clinical trial of genexol(paclitaxel) and cisplatin in patients with non-small cell lung cancer. Lung Cancer. 41. S278–S279. 1 indexed citations
16.
Park, Seokwoo, Kyungho Park, Sang‐Goo Lee, et al.. (2002). Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines. Head & Neck. 25(1). 44–49. 16 indexed citations
17.
Sung, Myung‐Whun, Seok‐Woo Park, Jong‐Lyel Roh, et al.. (2002). Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.. PubMed. 22(4). 2089–96. 41 indexed citations
18.
Kim, Suzy, Hong‐Gyun Wu, Dae‐Seog Heo, et al.. (2001). Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head & Neck. 23(9). 713–717. 35 indexed citations
19.
Cho, Kwang‐Hyun, et al.. (2000). Skin Is the Frequent Site for Involvement of Peripheral T‐Cell and Natural Killer Cell Lymphomas in Korea. The Journal of Dermatology. 27(8). 500–507. 13 indexed citations
20.
Heo, Dae‐Seog, et al.. (1998). Pain and Factors Influencing Its Management in Patients with Terminal Cancer. The Korean Journal of Hospice and Palliative Care. 1(1). 23–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026